Get to know our clinical trials
Phase 3, global, multicenter, randomized, double-blind, double-blind, controlled clinical trial with Propofol to evaluate the efficacy and safety of HSK3486 injectable emulsion in the induction of general anesthesia in adults undergoing elective surgery
THE OBJECTIVE OF THIS CLINICAL TRIAL IS TO LEARN ABOUT THE SAFETY AND EFFICACY (HOW WELL A DRUG WORKS) OF THE CLINICAL TRIAL DRUG (HSK3486) COMPARED TO PROPOFOL IN PATIENTS UNDERGOING SCHEDULED SURGERY WITH GENERAL ANESTHESIA USING ENDOTRACHEAL INTUBATION (IE).
Technical Summary
- PHASE 3, GLOBAL, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, DOUBLE-BLIND, CONTROLLED CLINICAL TRIAL WITH PROPOFOL TO EVALUATE THE EFFICACY AND SAFETY OF HSK3486 INJECTABLE EMULSION IN THE INDUCTION OF GENERAL ANESTHESIA IN ADULTS UNDERGOING ELECTIVE SURGERY
- Code EudraCT: 2023-507009-32-00
- Protocol number: HSK3486-309
- Promoter: Haisco Usa Pharmaceuticals Inc
* The trials only admit a limited number of patients and are subject to inclusion and exclusion criteria. The specialist who assesses your case will inform you of the conditions required to participate in the clinical trial.
More information about this clinical trial
Information offered by the Spanish Registry of Clinical Studies
- Summary
- Information
- Calendar
- Headquarters
- Drugs
Do you want to participate in this trial?
Request an appointment for our specialists to assess whether you qualify for this clinical trial
Do you prefer to send us your reports?
If you prefer, you can send us your medical information and our specialists will evaluate your case without the need to come to the Clinica.